1. | Age ≥ 40 and ≤ 75 years old |
2. | Heterogeneous emphysema with upper lobe predominance in both lungs |
3. | FEV1 between 20% and 45% predicted |
4. | Total lung capacity (TLC) ≥ 100% predicted |
5. | Residual volume (RV) > 150% predicted |
6. | Post-rehabilitation 6-minute walk test > 140 meters |
7. | Marked dyspnea scoring > 2 on the modified Medical Research Council scale (mMRC) |
8. | Arterial blood gas levels of: PaCO2 ≤ 50 mm Hg; PaO2 > 50 mm Hg on room air |
9. | Non-smoking for 6 months prior to study enrollment |
10. | Optimized medical management (treatment consistent with GOLD guidelines) |
11. | Evidence of completed pulmonary rehabilitation: |
a) ≥ 6 weeks out-patient or ≥ 3 weeks in-patient within 6 months of enrollment; or, | |
b) Patient has or continues to participate in regular physical activity beyond activities of daily living (i.e. a walking program) for ≥ 6 weeks under the supervision of a health care professional | |
12. | Mentally and physically able to cooperate with the study procedures and to provide informed consent to participate in the study. |